Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascual Sanz

Showing results (61-70 of 105) with videos related to

Pageof 11
Sort By:
The Journal of Biological Chemistry|December 5, 2006
YPI1 and SDS22 proteins regulate the nuclear localization and function of yeast type 1 phosphatase Glc7Leda Pedelini, Maribel Marquina, Joaquin Ariño, et al.
Plos One|August 8, 2013
Dimerization of the glucan phosphatase laforin requires the participation of cysteine 329Pablo Sánchez-Martín, Madushi Raththagala, Travis M Bridges, et al.
Glia|December 28, 2020
Endocytosis of the glutamate transporter 1 is regulated by laforin and malin: Implications in Lafora diseaseEva Perez-Jimenez, Rosa Viana, Carmen Muñoz-Ballester, et al.
Free Radical Biology & Medicine|February 21, 2012
Histone carbonylation occurs in proliferating cellsJosé Luis García-Giménez, Ana María Velázquez Ledesma, Isabel Esmoris, et al.
Molecular Neurobiology|January 29, 2015
Pharmacological Interventions to Ameliorate Neuropathological Symptoms in a Mouse Model of Lafora DiseaseArnaud Berthier, Miguel Payá, Ana M García-Cabrero, et al.
Plos One|September 3, 2011
Laforin, a dual specificity phosphatase involved in Lafora disease, is present mainly as monomeric form with full phosphatase activityVikas V Dukhande, Devin M Rogers, Carlos Romá-Mateo, et al.
International Journal of Molecular Sciences|December 30, 2025
Adeno-Associated Virus-Based Gene Therapy for Lafora Disease in <i>Epm2b</i>-Deficient MiceLuis Zafra-Puerta, Nerea Iglesias-Cabeza, Pascual Sanz, et al.
Epilepsy Research|July 25, 2018
A novel EPM2A mutation yields a slow progression form of Lafora diseaseMaria Adelaida Garcia-Gimeno, Pilar Natalia Rodilla-Ramirez, Rosa Viana, et al.
Experimental & Molecular Medicine|June 6, 2019
Metformin treatment reduces motor and neuropsychiatric phenotypes in the zQ175 mouse model of Huntington diseaseAna Sanchis, María Adelaida García-Gimeno, Antonio José Cañada-Martínez, et al.
Molecular Neurobiology|May 20, 2014
Increased oxidative stress and impaired antioxidant response in Lafora diseaseCarlos Romá-Mateo, Carmen Aguado, José Luis García-Giménez, et al.
Pageof 11

Showing results (61-70 of 105) with videos related to

Sort By:
Pageof 11
The Journal of Biological Chemistry|December 5, 2006
YPI1 and SDS22 proteins regulate the nuclear localization and function of yeast type 1 phosphatase Glc7Leda Pedelini, Maribel Marquina, Joaquin Ariño, et al.
Plos One|August 8, 2013
Dimerization of the glucan phosphatase laforin requires the participation of cysteine 329Pablo Sánchez-Martín, Madushi Raththagala, Travis M Bridges, et al.
Glia|December 28, 2020
Endocytosis of the glutamate transporter 1 is regulated by laforin and malin: Implications in Lafora diseaseEva Perez-Jimenez, Rosa Viana, Carmen Muñoz-Ballester, et al.
Free Radical Biology & Medicine|February 21, 2012
Histone carbonylation occurs in proliferating cellsJosé Luis García-Giménez, Ana María Velázquez Ledesma, Isabel Esmoris, et al.
Molecular Neurobiology|January 29, 2015
Pharmacological Interventions to Ameliorate Neuropathological Symptoms in a Mouse Model of Lafora DiseaseArnaud Berthier, Miguel Payá, Ana M García-Cabrero, et al.
Plos One|September 3, 2011
Laforin, a dual specificity phosphatase involved in Lafora disease, is present mainly as monomeric form with full phosphatase activityVikas V Dukhande, Devin M Rogers, Carlos Romá-Mateo, et al.
International Journal of Molecular Sciences|December 30, 2025
Adeno-Associated Virus-Based Gene Therapy for Lafora Disease in <i>Epm2b</i>-Deficient MiceLuis Zafra-Puerta, Nerea Iglesias-Cabeza, Pascual Sanz, et al.
Epilepsy Research|July 25, 2018
A novel EPM2A mutation yields a slow progression form of Lafora diseaseMaria Adelaida Garcia-Gimeno, Pilar Natalia Rodilla-Ramirez, Rosa Viana, et al.
Experimental & Molecular Medicine|June 6, 2019
Metformin treatment reduces motor and neuropsychiatric phenotypes in the zQ175 mouse model of Huntington diseaseAna Sanchis, María Adelaida García-Gimeno, Antonio José Cañada-Martínez, et al.
Molecular Neurobiology|May 20, 2014
Increased oxidative stress and impaired antioxidant response in Lafora diseaseCarlos Romá-Mateo, Carmen Aguado, José Luis García-Giménez, et al.
Pageof 11